We recently reviewed PwC’s Medical Technology Innovation Scorecard which assesses nine countries’ capacity and capability for medical technology innovation: Brazil, China, France, Germany, India, Israel, Japan, United Kingdom, United States.
- The medical technology innovation ecosystem, long centered in the United States, is moving offshore. Innovators are going outside the United States to seek clinical data, new-product registration, and first revenue.
- US consumers aren’t always the first to benefit from medical technology and could eventually be last. Innovators already are going first to market in Europe and, by 2020, likely will move into emerging countries next.
- The nature of innovation is changing as developing nations become the leading markets for smaller, faster, more affordable devices that enable delivery of care anywhere at lower cost.